dimethyldioctadecylammonium has been researched along with HIV in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agger, EM; Andersen, P; Berzofsky, JA; Billeskov, R; Frey, B; Kulkarni, S; Solaymani-Mohammadi, S; Sui, Y; Wang, Y | 1 |
1 other study(ies) available for dimethyldioctadecylammonium and HIV
Article | Year |
---|---|
Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective Efficacy.
Topics: Adjuvants, Immunologic; AIDS Vaccines; Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Cytokines; HIV; HIV Antigens; Humans; Liposomes; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Monoglycerides; Poly I-C; Quaternary Ammonium Compounds | 2017 |